.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Deloitte
UBS
Accenture
QuintilesIMS
Merck
Farmers Insurance
Boehringer Ingelheim
Cantor Fitzgerald
Chinese Patent Office

Generated: November 24, 2017

DrugPatentWatch Database Preview

Alfuzosin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for alfuzosin hydrochloride and what is the scope of alfuzosin hydrochloride patent protection?

Alfuzosin hydrochloride
is the generic ingredient in two branded drugs marketed by Apotex Inc, Mylan, Wockhardt Ltd, Torrent Pharms, Teva Pharms, Sun Pharma Global, Aurobindo Pharma Ltd, Invagen Pharms, Concordia Pharms Inc, and Unichem Labs Ltd, and is included in ten NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Alfuzosin hydrochloride has fifty-three patent family members in thirty-eight countries.

There are nineteen drug master file entries for alfuzosin hydrochloride. Twenty-one suppliers are listed for this compound.

Pharmacology for alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079060-001Aug 30, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Unichem Labs Ltd
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL203192-001Jan 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt Ltd
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL090221-001Aug 10, 2012DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079056-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Concordia Pharms Inc
UROXATRAL
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021287-001Jun 12, 2003ABRXYesYes► Subscribe► SubscribeY► Subscribe
Sun Pharma Global
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079057-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079014-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL090284-001Jan 17, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079054-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
ALFUZOSIN HYDROCHLORIDE
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL079013-001Jul 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: alfuzosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Concordia Pharms Inc
UROXATRAL
alfuzosin hydrochloride
TABLET, EXTENDED RELEASE;ORAL021287-001Jun 12, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: alfuzosin hydrochloride

Country Document Number Estimated Expiration
African Regional IP Organization (ARIPO)9901470► Subscribe
New Zealand334018► Subscribe
Denmark0938318► Subscribe
Cyprus2284► Subscribe
Portugal938318► Subscribe
European Patent Office0938318► Subscribe
Czech Republic295066► Subscribe
Hungary228007► Subscribe
South Korea20000035929► Subscribe
Iceland2091► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Farmers Insurance
Daiichi Sankyo
AstraZeneca
Colorcon
Cantor Fitzgerald
US Army
Merck
Argus Health
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot